Matches in Wikidata for { <http://www.wikidata.org/entity/Q64217197> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64217197 description "clinical trial" @default.
- Q64217197 description "ensayu clínicu" @default.
- Q64217197 description "klinisch onderzoek" @default.
- Q64217197 description "клінічне випробування" @default.
- Q64217197 name "Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus" @default.
- Q64217197 type Item @default.
- Q64217197 label "Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus" @default.
- Q64217197 prefLabel "Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus" @default.
- Q64217197 P1050 Q64217197-2CDCC849-634B-4C67-A3AF-250AA959D49E @default.
- Q64217197 P1132 Q64217197-177C6734-FC27-4EB2-B1B0-189F23AFDF9D @default.
- Q64217197 P1476 Q64217197-7EBEA3B6-81DA-413B-B89D-27E53E39997F @default.
- Q64217197 P17 Q64217197-88186BA1-9AAB-42F8-B9A5-05D32745997E @default.
- Q64217197 P2899 Q64217197-137B99C0-C1FB-4297-B209-B05628435AC8 @default.
- Q64217197 P3098 Q64217197-C9440021-4DAB-4A09-B6A4-D48C692FE53A @default.
- Q64217197 P31 Q64217197-135AC6DA-53B4-44B5-8984-AA3F8873F260 @default.
- Q64217197 P4135 Q64217197-6AEC7E26-A1E2-4F50-A005-B05E40195E3A @default.
- Q64217197 P580 Q64217197-06ADE434-B79D-4D51-8F5D-E38C2FC0BD1C @default.
- Q64217197 P582 Q64217197-98582AD0-8434-4FB5-A4AE-158C00B7E81E @default.
- Q64217197 P6099 Q64217197-3E4C680D-DE9A-44AF-BC5D-C8D96178EF38 @default.
- Q64217197 P6153 Q64217197-05011D9E-8C39-428C-93A9-7313DDA9CA92 @default.
- Q64217197 P6153 Q64217197-10478384-45B8-49F3-9443-FF59042B425D @default.
- Q64217197 P6153 Q64217197-1832BCD2-A542-40AE-B8B8-C148396D274E @default.
- Q64217197 P6153 Q64217197-972717B2-1219-4AD6-B41C-49D0AEFB0003 @default.
- Q64217197 P8363 Q64217197-FC2F2292-10F6-405E-9512-3B47E642ECCD @default.
- Q64217197 P1050 Q12206 @default.
- Q64217197 P1132 "+269" @default.
- Q64217197 P1476 "A 52-week Randomised, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Empagliflozin Once Daily, as an add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control" @default.
- Q64217197 P17 Q17 @default.
- Q64217197 P2899 "+20" @default.
- Q64217197 P3098 "NCT02589639" @default.
- Q64217197 P31 Q30612 @default.
- Q64217197 P4135 "+74" @default.
- Q64217197 P580 "2015-10-28T00:00:00Z" @default.
- Q64217197 P582 "2017-04-18T00:00:00Z" @default.
- Q64217197 P6099 Q42825046 @default.
- Q64217197 P6153 Q11469690 @default.
- Q64217197 P6153 Q11592482 @default.
- Q64217197 P6153 Q11627631 @default.
- Q64217197 P6153 Q3244340 @default.
- Q64217197 P8363 Q78089383 @default.